Citizens JMP analyst Constantine Davides upgraded Cross Country Healthcare (CCRN) to Outperform from Market Perform with an $11 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCRN:
- Cross Country Healthcare: Navigating Post-Acquisition Challenges with Financial Stability and Growth Potential
- Cross Country Healthcare Ends Merger with Aya Holdings
- Cross Country Healthcare, Aya Healthcare merger agreement terminated
- Cross Country Healthcare Reports Q3 2025 Financial Results
- Cross Country Healthcare’s Financial Stability at Risk: Unforeseen Challenges Ahead